US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Alterity Therapeutics Limited (ATHOA) 銘柄情報

Alterity Therapeutics Limited (ATHOA)

5.00

0.00

(0.00%)

終了 7月3日 3:00PM

Alterity Therapeutics Limited (ATHOA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

5.00

( - )

買値

0.043

売値

5.00

出来高

0.00

0.00 日の範囲 0.00

0.001 52 週間の範囲 0.006

時価総額

前日終値

5.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 146,094

発行済株式数

217,508,326

配当利回り

PER

-6.78

1 株当たり利益 (EPS)

-0.08

歳入

6.64M

純利益

-14.59M

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical tri... Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease. The company’s lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson’s disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

alteritytherapeutics.com

本社

Melbourne, Australia

設立

1997

Alterity Therapeutics Limited is listed in the sector of the オーストラリア証券取引所 with ticker ATHOA. The last closing price for Alterity Therapeutics was AUD5. Over the last year, Alterity Therapeutics shares have traded in a share price range of AUD 0.001 to AUD 0.006.

Alterity Therapeutics currently has 217,508,326 shares in issue. The market capitalisation of Alterity Therapeutics is AUD1.09 billion. Alterity Therapeutics has a price to earnings ratio (PE ratio) of -6.78.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	4.998	249900	0.002	0.003	0.001	1947820	0.00259017	DE
26	4.998	249900	0.002	0.003	0.001	1626030	0.00206111	DE
52	4.997	166566.666667	0.003	0.006	0.001	1391098	0.00296323	DE
156	4.998	249900	0.002	0.006	0.001	1866779	0.00282149	DE
260	4.998	249900	0.002	0.006	0.001	1866779	0.00282149	DE

ATHOA - Frequently Asked Questions (FAQ)

What is the current Alterity Therapeutics Limited share price?

The current share price of Alterity Therapeutics Limited is AUD 5.00

How many Alterity Therapeutics Limited shares are in issue?

Alterity Therapeutics Limited has 217,508,326 shares in issue

What is the market cap of Alterity Therapeutics Limited?

The market capitalisation of Alterity Therapeutics Limited is AUD 1.09B

What is the 1 year trading range for Alterity Therapeutics Limited share price?

Alterity Therapeutics Limited has traded in the range of AUD 0.001 to AUD 0.006 during the past year

What is the PE ratio of Alterity Therapeutics Limited?

The price to earnings ratio of Alterity Therapeutics Limited is -6.78

What is the cash to sales ratio of Alterity Therapeutics Limited?

The cash to sales ratio of Alterity Therapeutics Limited is 18.35

What is the registered address of Alterity Therapeutics Limited?

The registered address for Alterity Therapeutics Limited is 500 Collins Street, Melbourne, Victoria, 3000

What is the Alterity Therapeutics Limited website address?

The website address for Alterity Therapeutics Limited is alteritytherapeutics.com

justhefax

justhefax 5分前

yes, and could be in for a manufactured pop. But the dream is the new co that is featured and serious... and looking to build real lasting value.
But only 20%, and no understanding about their values, and team all remains uncertain.
If we see substantial new dilution , the current sel

CA Market News

CA Market News 6分前

Guanajuato Silver Announces AGM ResultsJuly 3, 2026 7:30 AM
ACCESS NewswireVANCOUVER, BC / ACCESS Newswire / July 3, 2026 / Guanajuato Silver Company Ltd. (the "Company"

US Market News

US Market News 6分前

PSE&G Urges Customers To Prepare for Continued Extreme Heat and Potential Thunderstorms Through the Holiday WeekendJuly 3, 2026 7:30 AM
PR Newswire (US) class="legendSpanClass"NEWARK, N.J., class="legendSpanClass"July 3, 2026 /PRNewswire

CA Market News

CA Market News 6分前

Nine Mile Metals Strengthens Capital Markets Strategy with Market-Making and Global Digital Media EngagementsJuly 3, 2026 7:41 AM
Newsfile

bubba412

bubba412 8分前

If they do a 15 to 1 reverse and the stock pps is 10 dollars you’ll be losing money

Wallstreeter$$$

Wallstreeter$$$ 8分前

If they had to respond to 40 reviewers as u claim, so what!? You assume thats a bad thing and not just part of the stringent process cuz Radiogel is a radioactive treatment so I would hope they'd go thru the sub with a fine tooth comb. But as u said its your opinion and we all know how much that's w

Lifetime

Lifetime 9分前

That is John Ellis not Einstein, Einstein.

brazen22

brazen22 11分前

It’s easy to tell when a post landed. Otherwise, the incoming would be rebuttals, not sophomoric cheap shots

chazzy1

chazzy1 15分前

"Definitions and explanations generated entirely by AI are not copyrightable. Under U.S. copyright law, a work must have human authorship to receive protection. If an AI tool writes the definitions for you, they enter the public domain and anyone can copy them freely."
Thus I have no concerns

GoodGuyBill

GoodGuyBill 18分前

Sage007, you can call my prior post “cow dung” all you want, but facts don’t disappear because you refuse to read them. Here is a clean, structured list of NWBO’s accomplishments and MHRA accommodations over the last three years — each with what it is and why it matters-- that you ignore or believe

mauiguy2

mauiguy2 19分前

They're promising us less than they promised back in 2022.

Good Day LuLa!

Since you've been a solid backer of CYB for many years, I was a bit surprised to read your unhappiness regarding the welcomed shareholder letter.

I can give you 2 credible reasons

Idunno

Idunno 21分前

Or, is it something else?

CA Market News

CA Market News 21分前

Founders Metals Appoints Felicia de la Paz as Chief Financial OfficerJuly 3, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfil

I am done

I am done 22分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Carome

Carome 23分前

I fell for a complex options strategy from a YouTube guru. I didn’t understand pin risk or early assignment, and I lost £2,800 when a spread went wrong. Laura G. Prescott on Facebook simplified everything: she taught me covered calls on stocks I already owned. She personally helped me pick the first

I am done

I am done 23分前

$BSAI BluSky AI Inc. Team building with the Appointment of Mort Aaronson to Board of Directors
https://www.globenewswire.com/news-release/2026/07/01/3320731/29006/en/BluSky-AI-Inc-Announces-Appointment-of-Mort-Aaronson-to-Board-of-Directors.html

Idunno

Idunno 26分前

Are you really on a high school debate club?

PennyMillions852

PennyMillions852 27分前

All time garbage lows…..0002x.0003

JACKPOT

JACKPOT 28分前

No. I don't have anywhere near that amount

reg2015

reg2015 29分前

From David Innes. Slide show will be posted later today on our website. Can't wait. Is NWBO trading today on the Brit's Exchange?
I hope it is doing well. Peace Reg2015

brazen22

brazen22 30分前

Yes, if the control-arm mOS drops, the apparent difference versus DCVax-L increases.

But that is exactly why the method matters.

If I were trying to make the most credible case for a new drug, I would want to show benefit against a strong, comparable control group, not

cottonisking

cottonisking 33分前

5 sites
In the Lehman Brothers Holdings Inc. (LBHI) Chapter 11 bankruptcy, the legal relationship between "satisfied in full" and "paid in full" became a critical, multi-billion-dollar distinction heavily litigated in court.

FindLaw Caselaw
The core difference is that a

JoeForkeyBolo

JoeForkeyBolo 33分前

Sorry, Zero, I realized I already have your email. I will send the updated drawdown calculator that supports my current drawdown strategy. You can use it or continue with what you're already doing.

Alterity Therapeutics

Amundi ETF MSCI World Ex...

Energy Transition Minerals

Qian Yuan Baixing (ID)

East West Minerals

1.625% TREASURY GILT 22/...

Melodiol Global Health

Core Energy Minerals

Source MSCI World UCTIS ...

Telefonica Brasil

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。